← Back to Clinical Trials
Recruiting NCT07358598

NCT07358598 Eye Movement Parameters and Cognitive Functions in Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07358598
Status Recruiting
Phase —
Sponsor National Sun Yat-sen University
Condition Cognitive Dysfunction
Study Type OBSERVATIONAL
Enrollment 210 participants
Start Date 2026-01-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 210 participants in total. It began in 2026-01-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Dementia most commonly occurs in elderly individuals, but currently there is still a lack of objective measurement methods that can detect cognitive impairment in older adults at an early stage. Eye movement is considered a clinical indicator with potential for screening mild cognitive dysfunction, and eye movement signals can be extracted to objectively evaluate cognition. Eye tracking has been used mostly to evaluate patients with neurodegenerative diseases such as Parkinson's disease. However, less attention has been paid to the relationship between eye movement and cognitive function in elderly individuals, as well as the association between eye movement data and abnormal cognitive subdomains. This cross-sectional study will recruit 0204 elderly individuals over the age of 65, divided into three groups (healthy group/mild cognitive impairment group/dementia group) according to the purpose of this study. Participants who have not been diagnosed with neurological diseases (such as Parkinson's disease or stroke), or have mental illness or visual impairments will be excluded. This study hopes to provide empirical data on eye movement signals and cognitive function in healthy older individuals, as well as to serve as a preliminary study for future development of eye activity stimulation to improve cognitive function in older adults.

Eligibility Criteria

Inclusion Criteria: \- Participants are aged 65 years or older and have completed a comprehensive geriatric assessment (CGA) in the outpatient clinic. Exclusion Criteria: * Participants are under 65 years of age or those who ar are unable to comply with study procedures.

Contact & Investigator

Central Contact

Yen Chin CHEN, Associated professor

✉ yenchin2427@gmail.com

📞 +886 7 5252000#7374

Frequently Asked Questions

Who can join the NCT07358598 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Cognitive Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07358598 currently recruiting?

Yes, NCT07358598 is actively recruiting participants. Contact the research team at yenchin2427@gmail.com for enrollment information.

Where is the NCT07358598 trial being conducted?

This trial is being conducted at Kaohsiung City, Taiwan.

Who is sponsoring the NCT07358598 clinical trial?

NCT07358598 is sponsored by National Sun Yat-sen University. The trial plans to enroll 210 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology